Lupin share news, announcements and annual reports
NSE: LUPINBSE: 500257Pharmaceuticals & BiotechnologyMid Cap
Lupin Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1993 on BSE, Sep 2001 on NSE
Last close ₹2,011.00up ₹21.10 (1.06%)BSE ₹2,009.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,989.90.
30 Oct: open ₹1,995.70, high ₹2,021.80, low ₹1,974.00
52-week range of traded prices to 30 Oct 2026
₹1,892.90Low, 23 Oct 2026₹2,529.50High, 16 Jul 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹91,961 Cr105th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 16.63
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹558 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 15.11
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.10
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.90%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹558 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 30.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 28.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.26
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,59,66358.6% delivered
Lupin share news and announcements
2,113 announcements, routine notices left out, newest first. Page 40 of 43.
May 2009
18 May · Disclosure
Disclosure in terms of the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 1992, in respect of change in holdings of Equity Shares of Rs. 10/- each in the Company, by Officer(s) of the Company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 May · Results
Consolidated Results for the year ended on 31-MAR-2009 as follows: Net Sales of Rs. 377588 lacs for year ending on 31-MAR-2009 against Rs. 270637 lacs for the year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 50154 lacs for the year ending on 31-MAR-2009 against Rs. 40825 lacs for the year ending on 31-MAR-2008.13 May · Business
Press release dated May 13, 2009, titled "Lupin FY 2008-09 Consolidated Net Profits up 50.2% to Rs 5015 mn". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 May · Results
Consolidated Results for the quarter ended on 31-MAR-2009 as follows: Net Sales of Rs. 104335 lacs for quarter ending on 31-MAR-2009 against Rs. 75038 lacs for the quarter ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 15738 lacs for the quarter ending on 31-MAR-2009 against Rs. 9587 lacs for the quarter ending on 31-MAR-2008.13 May · Results
Standalone Results for the year ended on 31-MAR-2009 as follows: Net Sales of Rs. 289856 lacs for year ending on 31-MAR-2009 against Rs. 254369 lacs for the year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 41697 lacs for the year ending on 31-MAR-2009 against Rs. 44338 lacs for the year ending on 31-MAR-2008.13 May · Results
Standalone Results for the quarter ended on 31-MAR-2009 as follows: Net Sales of Rs. 70460 lacs for quarter ending on 31-MAR-2009 against Rs. 61957 lacs for the quarter ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 8837 lacs for the quarter ending on 31-MAR-2009 against Rs. 7664 lacs for the quarter ending on 31-MAR-2008.13 May · Dividend
Board of Directors of the Company at its meeting held on May 13, 2009 have recommended dividend @ 125% i.e. Rs.12.50 per equity share of the face value of Rs.10/- each for the year ended March 31, 2009.11 May · Business
Press release dated May 11, 2009, titled "Lupin announces Litigation Settlement with Wyeth for Venlafaxine Extended Release Capsules". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2009
28 Apr · Allotment of Equity Shares
Allotment Committee of Directors at its meeting held on April 28, 2009 has allotted 8400 fully paid up equity shares of Rs.10/- each. These shares have been allotted upon exercising the options granted to the employees under the Stock Option Plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs. 828,279,500 consisting 82,827,950 equity shares of Rs.10/- each.23 Apr · Disclosure
Disclosure for change in shareholding in the Company. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Apr · Board meeting
Inter alia, to consider the audited accounts for the year ended March 31, 2009 and recommend dividend, if any.9 Apr · Business
Press release dated April 09, 2009, titled "Lupin in alliance with Natco; Alliance to commercialize generic equivalent of FOSRENOL(R) Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Apr · Disclosure
Disclosure in terms of the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 1992, in respect of holdings of Equity Shares of Rs. 10/- each in the Company, by Officer of the Company, Udayan S Ambegaokar. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Apr · Disclosure
Disclosure in terms of the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 1992, in respect of holdings of Equity Shares of Rs. 10/- each in the Company, by Officer of the Company, Satish S. Khanna. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Apr · Results
The last accounting year of the Company ended on March 31, 2009 and we intend to finalise and publish the audited results for the said year within the time stipulated by Clause 41 of the Listing Agreement. In view of the above, publication of the unaudited results for the last quarter i.e. January 01, 2009 to March 31, 2009 would not necessary.
Mar 2009
26 Mar · Business
Press release dated March 26, 2009, titled "Lupin in Equity Partnership with Multicare Pharmaceuticals Philippines, Inc.". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.26 Mar · Disclosure
Disclosure in terms of the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 1992, in respect of holdings of Equity Shares of Rs. 10/- each in the Company, by Officer(s) of the Company, Vijaykumar A Kothiwale and Rajeev C Paliwal. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Mar · Disclosure
Disclosure in terms of the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 1992, in respect of holdings of Equity Shares of Rs. 10/- each in the Company, by Officer(s) of the Company, Bosco Caridade Martins. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements) For more details click here.24 Mar · Allotment of Equity Shares
The Allotment Committee of Directors at its meeting held on March 24, 2009 has allotted 1750 fully paid up equity shares of Rs.10/- each. These shares have been allotted upon exercising of options granted to the employees under the Stock Option Plans of the Company. In view of the above, the issued and paid up capital of the Company increased to Rs.828,195,500 consisting 82,819,550 equity shares of Rs. 10/- each.18 Mar · Disclosure
Disclosure in terms of the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 1992, in respect of holdings of Equity Shares of Rs. 10/- each in the Company, by Officer(s) of the company, Mr. Lalit Singhal. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements) For more details click here.9 Mar · Business
Press release dated March 09, 2009, titled "Lupin ties up with leading Institutes for PhD Program". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Mar · Disclosure
Summary of continual disclosures in terms of the provisions of the SEBI( Prohibition of Insider Trading) Regulation, 1992. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2009
25 Feb · Allotment of Equity Shares
The Allotment Committee of Directors at its meeting held on February 25, 2009 has allotted 16568 fully paid up equity shares of Rs.10/- each. These shares have been allotted upon exercising of options granted to the employees under the Stock Option Plans of the Company. In view of the above, the issued and paid up capital of the Company increased to Rs.828,178,000 consisting 82,817,800 equity shares of Rs. 10/- each.12 Feb · Disclosure
Disclosure pursuant to Regulation 8A(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Feb · Grant of Options
The Company has granted 59500 options under 'Lupin Employees Stock Option Plan 2005' to its employees at the exercise price of Rs. 573.20 on February 5, 2009. Please note that one equity share of Rs. 10/- each is covered by each option. The options issued are exercisable at the 'market price' as defined in SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant4 Feb · Disclosure
Summary of continual disclosures in terms of the provisions of the SEBI( Prohibition of Insider Trading) Regulation, 1992. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
29 Jan · Business
Press release dated January 29, 2009 titled "Lupin Q3 FY 08-09 - Strong Growth & Consistent Performance; Consolidated Sales up 32% to Rs.9719 Mn, Net Profit - Rs 1165 Mn". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.29 Jan · Results
Consolidated Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 96184 lacs for quarter ending on 31-DEC-2008 against Rs. 72129 lacs for the quarter ending on 31-DEC-2007. Net Profit / (Loss) of Rs. 11650 lacs for the quarter ending on 31-DEC-2008 against Rs. 18090 lacs for the quarter ending on 31-DEC-2007.29 Jan · Results
Standalone Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 72886 lacs for quarter ending on 31-DEC-2008 against Rs. 60805 lacs for the quarter ending on 31-DEC-2007. Net Profit / (Loss) of Rs. 8814 lacs for the quarter ending on 31-DEC-2008 against Rs. 17028 lacs for the quarter ending on 31-DEC-2007.29 Jan · Allotment of Equity Shares
Allotment Committee of Directors at its meeting held on January 29, 2009 has allotted 7823 fully paid up equity shares of Rs. 10/- each. These shares have been allotted upon exercising of options granted to the employees under the Stock Option Plans of the Company. In view of the above, the issued and paid up capital of the Company increased to Rs. 828,012,320 consisting 82,801,232 equity shares of Rs. 10/- each.16 Jan · Business
Press release dated January 16, 2009, titled "Lupin receives USFDA approval for Levetiracetam Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Jan · Board meeting
Meeting on 29 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”9 Jan · Grant of Stock Options
The Company has granted 10000 options under Lupin Employees Stock Option Plan 2005 at the exercise price of Rs. 292.53 on January 08, 2009. Please note that one equity share of Rs.10/- each is covered by each option. The options issued are exercisable after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant5 Jan · Disclosure
Summary of Continual Disclosure of Shareholding in the Company pursuant to Clause 13 of SEBI (Prohibition of Insider Trading) Regulations, 1992. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Dec 2008
29 Dec · Disclosure
Summary of Continual Disclosure of Shareholding in the Company pursuant to Clause 13 of SEBI (Prohibition of Insider Trading) Regulations, 1992. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Dec · Disclosure
Summary of Continual Disclosure of Shareholding in the Company pursuant to Clause 13 of SEBI (Prohibition of Insider Trading) Regulations, 1992. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Dec · Business
Press release dated December 17, 2008, titled "Lupin Announces Litigation Settlement with Schering-Plough Corporation for Desloratadine". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Dec · Allotment of Equity Shares
The Allotment Committee of Directors at its meeting held on December 15, 2008 has allotted 3065 fully paid up equity shares of Rs.10/- each. These shares have been allotted upon exercising of options granted to the employees under the Stock Option Plans of the Company. In view of the above, the issued and paid up capital of the Company increased to Rs.827,934,090 consisting 82,793,409 equity shares of Rs.10/- each12 Dec · Business
Press release dated December 12, 2008, titled "Lupin appoints Divakar Kaza as President- Human Resources". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Dec · Results
Result of postal ballot seeking their approval for:- (i) the re-appointment of Dr. Kamal K. Sharma as Managing Director of the Company for a period of four years w.e.f. September 29, 2008 and approve the remuneration payable to him (Ordinary Resolution), (ii) the appointment of Mr. Nilesh Gupta as Executive Director of the Company for a period of five years w.e.f. October 8, 2008 and approve the remuneration payable to him (Special Resolution), and (iii) altering the "Lupin Employees Stock Option Plan 2003" (Special Resolution). As per the said results, Ordinary Resolution as mentioned in (i) was passed by majority. Special Resolution as mentioned in (ii) was passed by Special majority. Also the Special Resolution as mentioned in (iii) was passed by Special majority. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2008
14 Nov · Business
Press release dated November 13, 2008 , titled "Lupin announces results of US FDA Inspection ". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 Nov · Meeting
Pursuant to the provisions of Section 192A of the Companies Act, 1956 ('Act') read with the Companies (Passing of the Resolution by postal ballot) Rules, 2001 the Company is seeking their approvals by Postal ballot for following matters: 1) The re-appointment of Dr. Kamal K. Sharma as Managing Director of the Company for a period of four years w.e.f. September 29, 2008 and approve the remuneration payable to him (an Ordinary Resolution). 2) The appointment of Mr. Nilesh Gupta as Executive Director for a period of five years w.e.f. October 08, 2008 and approve the remuneration payable to him (a Special Resolution) and 3) Altering the "Lupin Employees Stock Option Plan 2003" (a Special Resolution). The Company has appointed Ms. Neena Bhatia, Practising Company Secretary, as the Scrutinizer for conducting the Postal Ballot process in a fair and transparent manner. The Postal Ballot form should reach the Scrutinizer on or before the close of working hours on November 27, 2008. The Scrutinizer will submit her report to the Chairman of the Company after completion of the Scrutiny and the result of the postal ballot will be announced on November 28, 2008. A copy of notice of the Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Nov · Disclosure
Summary of Continual Disclosure of Shareholding in the Company pursuant to Clause 13 of SEBI (Prohibition of Insider Trading) Regulations, 1992. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2008
24 Oct · Results
Consolidated Results for the half year ended on 30-SEP-2008 as follows: Net Sales of Rs. 177069 lacs for half year ending on 30-SEP-2008 against Rs. 123470 lacs for the half year ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 22766 lacs for the half year ending on 30-SEP-2008 against Rs. 13140 lacs for the half year ending on 30-SEP-2007.24 Oct · Results
Consolidated Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 90837 lacs for quarter ending on 30-SEP-2008 against Rs. 65897 lacs for the quarter ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 11562 lacs for the quarter ending on 30-SEP-2008 against Rs. 7556 lacs for the quarter ending on 30-SEP-2007.24 Oct · Business
Press release dated October 24, 2008 titled " Lupin Q2 FY 08-09 - Strong Performance & Strategic Growth - Consolidated Net Profit up 53% to Rs.1156 Mn, Sales at Rs 9221 Mn up by 36%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Oct · Results
Standalone Results for the half year ended on 30-SEP-2008 as follows: Net Sales of Rs. 146510 lacs for half year ending on 30-SEP-2008 against Rs. 131607 lacs for the half year ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 24046 lacs for the half year ending on 30-SEP-2008 against Rs. 19646 lacs for the half year ending on 30-SEP-2007.24 Oct · Results
Standalone Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 75268 lacs for quarter ending on 30-SEP-2008 against Rs. 71432 lacs for the quarter ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 13194 lacs for the quarter ending on 30-SEP-2008 against Rs. 11808 lacs for the quarter ending on 30-SEP-2007.17 Oct · Allotment of Equity Shares
The Allotment Committee of Directors at its meeting held on October 17, 2008 has allotted 4,95,938 fully paid up equity shares of Rs.10/- each, the particulars of which are as under:- (1) Shares issued upon : exercising the options granted to employees under the stock option plans of the Company; No of shares : 6450. (2) Shares issued upon : conversion of Zero Coupon Foreign Currency Convertible Bonds (FCCB) issued by the Company pursuant to the Offering Memorandum dated January 2, 2006; No. of shares : 489488. Total : 495938. In view of the above, the issued and paid up capital of the Company increased to Rs.827,903,440 consisting 82,790,344 equity shares of Rs.10/- each14 Oct · Board meeting
Meeting on 24 Oct 2008: “Unaudited financial results for qtr ended September 30, 2008”